Healthcare Providers

 Provider Information and Guidance

• Providers should report patients diagnosed with Arboviral Disease including West Nile virus, Eastern Equine Encephalitis, St. Louis Encephalitis, Chikungunya, etc., and Dengue, Yellow fever, and Zika virus within 3 days of diagnosis by using the online REPORT Card for Reportable Diseases/Conditions. 

Arboviral Diseases

• Medscape: Diagnosis and Management of West Nile Virus Infection
• West Nile Virus Diagnostic Algorithm
• CDC West Nile Virus Information and Guidance for Clinicians
• CDC West Nile and Blood Transfusion and Organ Donation
• CDC West Nile Statistics and Maps

Chikungunya

• Chikungunya Vaccine

Dengue

• Health Alert Network (HAN) Health Advisory for Dengue
• Dengue Clinical Management Pocket Guide

Malaria

In light of the 2023 US domestic malaria outbreak, the Domestic Response Team (DRT) within the CDC/Division of Parasitic Diseases and Malaria (DPDM), Malaria Branch developed the Malaria Surveillance & Case Investigation Best Practices resources. In addition to providing details on case definitions, presenting nuances related to reporting a malaria relapse vs. recrudescence, it also provides resources on malaria lifecycles and illness timelines, a quick reference for malaria diagnosis and treatment, and a list of links to malaria resources.

Zika

New CDC Zika Testing Guidance

Based on the current global epidemiology of Zika and dengue viruses, the Centers for Disease Control and Prevention (CDC) has recommended that state health departments and laboratories review and update their Zika virus testing practices. Routine serological testing for Zika virus is no longer recommended. Further details and changes that will affect the testing practices that we at the Alabama Department of Public Health recommend and provide are detailed below.

• Update: New Zika and Dengue Testing Guidance

Consulation and Testing

• Providers must complete the online consultation form to request approval for Zika virus testing through our public health laboratory. Any provider with a scenario that has not been specifically addressed or with additional questions or concerns may call the Infectious Diseases & Outbreaks Division at 1-800-338-8374 for consultation and assistance. The form can be accessed online.
• ADPH BCL Requisition Form for Laboratory Testing (Fillable PDF)
• Form 50.34: CDC Specimen Submission Form: Specimens of Human Origin (Try using another browser, such as Internet Explorer, if Form 50.34 will not load.)

Information for Providers with Pregnant Women

• CDC Vital Signs: Protecting Pregnant Women and Babies
• MMWR: Zika Virus-Associate Birth Defects
• Clinical Guidance for Healthcare Providers Caring for Pregnant Women (CDC)
• List of Zika Pregnancy Outcomes-Brain Abnormalities and Other Adverse Outcomes
• MMWR publication: Description of 13 Infants Born During October 2015 - January 2016 With Congenital Zika Virus Infection Without Microencephaly at Birth - Brazil

Additional Resources

• Clinical Guidance for Immunocompromised Patients

For questions or concerns regarding insect-borne disease in Alabama, see Contact Us, or email us at [email protected]